The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AQUABOUNTY TECHNOLOGIES INC | COM NEW | 03842K200 | 23,234 | 14,253,912 | SH | SOLE | 14,253,912 | 0 | 0 | ||
| EMERGENT BIOSOLUTIONS INC | COM | 29089Q105 | 220 | 3,810 | SH | SOLE | 3,810 | 0 | 0 | ||
| ENERGY TRANSFER LP | COM UT LTD PTN | 29273V100 | 4,940 | 1,073,990 | SH | SOLE | 1,073,990 | 0 | 0 | ||
| ENTERPRISE PRODS PARTNERS L | COM | 293792107 | 16,241 | 1,135,734 | SH | SOLE | 1,135,734 | 0 | 0 | ||
| HALOZYME THERAPEUTICS INC | COM | 40637H109 | 126,799 | 7,048,282 | SH | SOLE | 7,048,282 | 0 | 0 | ||
| NUSTAR ENERGY LP | UNIT COM | 67058H102 | 1,247 | 145,200 | SH | SOLE | 145,200 | 0 | 0 | ||
| ORAGENICS INC | COM PAR | 684023302 | 2,675 | 4,612,166 | SH | SOLE | 4,612,166 | 0 | 0 | ||
| PRECIGEN INC | COM | 74017N105 | 281,488 | 82,790,616 | SH | SOLE | 82,790,616 | 0 | 0 | ||
| PTC THERAPEUTICS INC | COM | 69366J200 | 6,136 | 137,551 | SH | SOLE | 137,551 | 0 | 0 | ||
| TC PIPELINES LP | UT COM LTD PRT | 87233Q108 | 2,666 | 97,000 | SH | SOLE | 97,000 | 0 | 0 | ||
| ZIOPHARM ONCOLOGY INC | COM | 98973P101 | 49 | 20,144 | SH | SOLE | 20,144 | 0 | 0 | ||